Fig. 7From: WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapyCorrelation between the expression of WDR76 with markers of immune cell subtypes and immune checkpoints. A CD163. B MS4A4A. C CCR7. D HLA–DPB1. E PDCD1. F CD96. G LAG3. H KLRB1. I CD276. J IDO1Back to article page